DISPOSITION OF PROPOFOL AT CESAREAN-SECTION AND IN THE POSTPARTUM PERIOD

被引:28
作者
GIN, T
YAU, G
JONG, W
TAN, P
LEUNG, RKW
CHAN, K
机构
[1] CHINESE UNIV HONG KONG, PRINCE WALES HOSP, DEPT PAEDIAT, SHA TIN, HONG KONG
[2] CHINESE UNIV HONG KONG, DEPT PHARMACOL, SHA TIN, HONG KONG
关键词
ANESTHESIA; OBSTETRIC; ANESTHETICS; INTRAVENOUS; PROPOFOL; PHARMACOKINETICS; PREGNANCY; PUERPERIUM;
D O I
10.1093/bja/67.1.49
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We have compared the pharmacokinetics of a bolus dose of propofol 2 mg kg-1 in eight patients undergoing Caesarean section with those in eight postpartum patients undergoing sterilization by mini-laparotomy. The Ceasarean section group had a total body clearance of (median) 31.5 (range 24.4-53.3) ml min-1 kg-1, apparent volume of distribution at steady state 5.10 (2.46-6.61) litre kg-1 and mean residence time 161 (52.3-251) min; values for the postpartum group were 33.8 (21.5-47.2) ml min-1 kg-1, 5.17 (3.47-8.09) litre kg-1 and 163 (92.3-238) min, respectively. The 95% confidence interval for the umbilical venous to maternal venous ratio of propofol at delivery was 0.62-0.86. Plasma protein binding studies showed there was less unbound propofol in maternal plasma (1.28-2.29%) compared with umbilical plasma (2.08-3.88%) (P < 0.01). Neonatal concentrations of propofol were greater than maternal concentrations at 2 h and were in the range of 0.05-0.11-mu-g ml-1 at 4 h.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 20 条
[1]   PRINCIPLES OF DRUG BIODISPOSITION IN THE NEONATE - A CRITICAL-EVALUATION OF THE PHARMACOKINETIC-PHARMACODYNAMIC INTERFACE .1. [J].
BESUNDER, JB ;
REED, MD ;
BLUMER, JL .
CLINICAL PHARMACOKINETICS, 1988, 14 (04) :189-216
[2]   EXTENDED BLOOD COLLECTION PERIOD REQUIRED TO DEFINE DISTRIBUTION AND ELIMINATION KINETICS OF PROPOFOL [J].
CAMPBELL, GA ;
MORGAN, DJ ;
KUMAR, K ;
CRANKSHAW, DP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (02) :187-190
[3]   NEUROBEHAVIOURAL EFFECTS OF PROPOFOL ON THE NEONATE FOLLOWING ELECTIVE CESAREAN-SECTION [J].
CELLENO, D ;
CAPOGNA, G ;
TOMASSETTI, M ;
COSTANTINO, P ;
DIFEO, G ;
NISINI, R .
BRITISH JOURNAL OF ANAESTHESIA, 1989, 62 (06) :649-654
[4]   PHARMACOKINETICS OF THIOPENTAL IN CESAREAN-SECTION [J].
CHRISTENSEN, JH ;
ANDREASEN, F ;
JANSEN, JA .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1981, 25 (02) :174-179
[5]  
COUPER J L, 1988, Canadian Journal of Anaesthesia, V35, pS132
[6]   INTRAVENOUS PROPOFOL DURING CESAREAN-SECTION - PLACENTAL-TRANSFER, CONCENTRATIONS IN BREAST-MILK, AND NEONATAL EFFECTS - A PRELIMINARY-STUDY [J].
DAILLAND, P ;
COCKSHOTT, ID ;
LIRZIN, JD ;
JACQUINOT, P ;
JORROT, JC ;
DEVERY, J ;
HARMEY, JL ;
CONSEILLER, C .
ANESTHESIOLOGY, 1989, 71 (06) :827-834
[7]  
Dunlop W., 1989, FETAL MED REV, V1, P43, DOI [10.1017/S0965539500000073, DOI 10.1017/S0965539500000073]
[8]  
GIBALDI M, 1982, DRUGS PHARM SCI, V15, P409
[9]   MATERNAL AND FETAL LEVELS OF PROPOFOL AT CESAREAN-SECTION [J].
GIN, T ;
GREGORY, MA ;
CHAN, K ;
OH, TE .
ANAESTHESIA AND INTENSIVE CARE, 1990, 18 (02) :180-184
[10]   PHARMACOKINETICS OF PROPOFOL IN WOMEN UNDERGOING ELECTIVE CESAREAN-SECTION [J].
GIN, T ;
GREGORY, MA ;
CHAN, K ;
BUCKLEY, T ;
OH, TE .
BRITISH JOURNAL OF ANAESTHESIA, 1990, 64 (02) :148-153